PE Firm · Capital Allocator

Bering Capital

Medium
Headquarters not yet mapped · Website
Last verified
10/11/2026

Firm Overview

14
Portfolio tracked
0
Sectors
0
Regions
10/11/2026
Last verified

Private investment firm focused on lower middle-market businesses.

Leadership

Evgeny Zaytsev MD, PhD
Managing Partner
Philip Sawyer
Managing Partner
Graeme Currie, PhD
Venture Partner
Christopher Alafi, DPhil
Advisor
George Painter, PhD
Advisor
Stephen A. Sherwin, MD
Advisor
Gregory B. Brown, MD
Advisor

Portfolio Companies

CompanySectorStatusWebsite
Atea Pharmaceuticals—Exited—
Calcimedica—Current—
Cellworks—Current—
Coherus BioSciences—Exited—
Coherus Oncology—Current—
Dragon Vascular—Current—
FocalTherics—Current—
Fusion Medical—Exited—
Invuity—Exited—
Leap Therapeutics—Exited—
Life Detection Technologies—Current—
Neuvogen—Current—
Onco Response—Current—
Precision Pharmaceuticals—Current—

Source: https://beringcapital.com/companies

Portfolio Web Readiness

Not yet assessed

The assessment covers whether AI crawlers and search engines can reach and parse the public site, page performance, transport and security hygiene, and discoverability.

Observational measurements of these companies' public websites only. Not a rating of the companies, their performance, their management, or their investment merit. Not investment advice. Request a correction or removal via Submit Update.

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with Bering Capital and does not provide investment advice.

More PE firms

Browse the full PE firms directory.